Consistency of multicenter measurements of heart rate variability in survivors of acute myocardial infarction

Reproducibility of 24-h heart rate variability in children

BACKGROUND

Over the last decades, time domain heart rate (HR) variability analysis has been explored in different pediatric clinical settings to obtain information on the cardiac autonomic tone. However, the consistency over time of 24 h time domain HRV measurements in children is not well-known.

METHODS

We investigated the reproducibility of 24 h HRV time-domain indices (1 day apart), from 39 healthy children (9.5 ± 5.3 years, 56.4% girls). The parameters analysed included: standard deviation of all the adjacent NN intervals, standard deviation of the averages of NN intervals (the intervals between normal R-peaks) in all 5-min segments, and square root of the mean of the sum of the squares of the differences between adjacent NN intervals, uncorrected and corrected for HR. Reproducibility between two 24-h ECG recordings was evaluated by intraclass correlation coefficients, standard error of measurement, coefficients of variation and Bland-Altman plots.

RESULTS

For the analyzed time-domain indices, standard deviation of all the adjacent NN intervals corrected for HR showed best reproducibility with the highest intraclass correlation coefficient (0.987), the lowest coefficients of variation (5.5%) and the best level of agreement between two recordings as assessed by Bland-Altman plots.

CONCLUSIONS

Our results indicate that the standard deviation of all the adjacent NN intervals corrected for the HR parameter obtained from 24-h ambulatory recordings in children is consistent and reproducible over time, thus allowing reliable identification of cardiac autonomic tone in this age group.

Heart rate variability by triangular index in infants exposed prenatally to cocaine

BACKGROUND

In adults, heart rate variability triangular index (HRVi) is a highly reproducible measure of heart rate variability (HRV), which makes it more suitable for use in longitudinal studies. Although normative data have been published for newborns, studies in infants with pathological conditions are lacking.

METHODS

From 1997 to 2000, within the first 4 days of life, we prospectively evaluated HRVi in cocaine-exposed asymptomatic newborns (N = 97) by Holter monitoring. Their data were compared with infants from two control groups (one with no in utero drug exposure, N = 102; the other with exposure to alcohol, nicotine, or marijuana but no cocaine, N = 111).

RESULTS

In assessing concordance between and within operators for HRVi, the intraclass correlations were 0.983 (95% CI: 0.958, 0.994) and 0.997 (95% CI: 0.984, 0.999), respectively. Infants with in utero cocaine exposure had significantly (P < 0.0001) lower HRVi than those exposed to other drugs and to no drugs in utero. If abnormal HRVi is defined as < fifth percentile for the no drug exposed group (HRVi < 8), 10% of the cocaine-exposed newborns, in contrast to 2% in each of the control groups (P = 0.003) had abnormal values.

CONCLUSION

HRVi is a reliable measure to study heart rate variability in newborns. Asymptomatic infants with in utero cocaine exposure have lower HRVi. Our study supports the clinical use of an abnormal HRVi as a value < 8 for newborn infants.

Changes in Heart Rate Variability Are Correlated to Hemodynamic Improvement With Chronic CARVEDILOL Therapy in Heart Failure

BACKGROUND

Reduced heart rate variability (HRV) has been shown to predict mortality in heart failure (CHF). The relationship between improved cardiac function and improvement in HRV has not been previously studied.

METHODS AND RESULTS

This was substudy of a randomized, placebo-controlled, double-blinded trial of carvedilol of four months duration. Analysis of HRV was performed on 24-hour Holter monitors obtained at baseline and completion of study. All subjects had symptomatic CHF and an left ventricular ejection fraction (LVEF) <0.35. Study medication was titrated over 1 month to 50 mg/day (< or =75 kg) or 100 mg/day (<75 kg). A total of 17 subjects were randomized to carvedilol and 12 to placebo. Treatment with carvedilol was associated with significant increases in total frequency power, very low frequency power, high frequency power, SDNN, the root-mean square of difference of successive RRs, and pNN50. Change in time and frequency domain measures of HRV had a positive correlation with change in LVEF and negative correlation with change in coronary sinus norepinephrine levels.

CONCLUSION

Carvedilol therapy in patients with CHF significantly increased HRV. Change in HRV correlates to improved hemodynamics. This suggests that carvedilol therapy partially normalizes autonomic modulation of heart rate in patients with CHF.

Reliability of three commercially available heart rate variability instruments using short-term (5-min) recordings

AIM

To assess the reliability of heart rate variability (HRV) measures made by three commercially available analysers in healthy subjects.

METHODS

Twenty-nine volunteers (20 males, mean age 35 +/- 13 years and nine females, mean age 29 +/- 11 years) underwent repeated HRV measures under three conditions: lying supine, standing, lying supine with controlled breathing. HRV was measured simultaneously by three instruments. Reliability was assessed statistically by calculating coefficient of variation (CV), intraclass correlation coefficient (ICC) and limits of agreement (LoA).

RESULTS

A wide range of values were found for CV (1-235%) and ICC (R = 0.16-0.99) dependent on the HRV measure assessed and the position in which the measurement was made. For the most part the analysers gave similar values in each condition. The values for CV and ICC were high but within the range reported in the literature. Values for LoA were also high and showed a wide range of values.

CONCLUSIONS

The similarity in measures between systems indicates that biological variation and experimental error play a major role in determining the repeatability of HRV measurements. It is therefore recommended that population-specific reliability coefficients should be published where possible and that authors should take into account the reliability of measures when making sample size calculations.

Agreement between three commercially available instruments for measuring short-term heart rate variability

Numerous instruments are commercially available to measure heart rate variability, yet little is known regarding the agreement between such instruments. The objective of this study is to assess agreement between measures of heart rate variability in three commercially available instruments. Thirty subjects (20 males) of median age 27.5 (range 19-59 years) underwent simultaneous ECG recordings, under three different resting conditions: supine, standing and supine with controlled breathing, using three commercially available analysers. Intraclass correlation coefficients tended to show excellent agreement (lower 95% C.I., R > 0.75) between all instruments under all conditions. However, further analysis of selected measurements using the limits of agreement method revealed large variation in values generated by all instruments. There was also an evidence of systematic bias between one instrument and the remaining two. The latter finding was due to discrepant ECG recording protocols that were unrelated to consistent operator timing. This study demonstrates that measures of HRV generated by the three instruments did not agree well in all cases. Discrepancies were due to the recording protocols of the systems. This may lead to incomparable results between instruments. It is therefore recommended that: (a) if different instruments are used in the same study or (b) multi-centre study designs are planned or (c) heart rate variability results are discussed with reference to studies using other instruments, levels of agreement need to be reported to ensure comparability.